miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity

Clinical therapy of doxorubicin (DOX) is limited due to its cardiotoxicity. miR-146a was proved as a protective factor in many cardiovascular diseases, but its role in chronic DOX-induced cardiotoxicity is unclear. The objective of this study was to demonstrate the role of miR-146a in low-dose long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jian-An, Tang, Yong, Yu, Jian-Ying, Zhang, Hui, Zhang, Jun-Feng, Wang, Chang-Qian, Gu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739392/
https://www.ncbi.nlm.nih.gov/pubmed/31511497
http://dx.doi.org/10.1038/s41419-019-1901-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739392/
https://www.ncbi.nlm.nih.gov/pubmed/31511497
http://dx.doi.org/10.1038/s41419-019-1901-x

Ejemplares similares